Cytomx Therapeutics, Inc. · NASDAQ:CTMX
State Street Corp reported a 5.40% stake in Cytomx Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 7, 2026
State Street Corp reported a 5.40% stake in Cytomx Therapeutics, Inc., 11,747,236 shares, as a passive investor on Jun 30, 2026. Filed Aug 7, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 11,747,236
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.40% | 11,747,236 |
Source
Related
- Cytomx Therapeutics, Inc.
- State Street Corp
- Cytomx Therapeutics, Inc. shareholders
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026